Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.
about
Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychoticsCalendar time-specific propensity score analysis for observational data: a case study estimating the effectiveness of inhaled long-acting beta-agonist on asthma exacerbations.The effectiveness of the cardiovascular disease prevention programme 'KardioPro' initiated by a German sickness fund: a time-to-event analysis of routine data.Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.Model Misspecification When Excluding Instrumental Variables From PS Models in Settings Where Instruments Modify the Effects of Covariates on TreatmentSequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events.Matching on the disease risk score in comparative effectiveness research of new treatmentsComparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis.Validity of the Danish National Registry of Patients for chemotherapy reporting among colorectal cancer patients is highAssessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study.Effectiveness of Drugs in Routine Care: A Model for Sequential Monitoring of New Medicines Using Dronedarone as Example.Pre-study feasibility and identifying sensitivity analyses for protocol pre-specification in comparative effectiveness research.Instrumental variable additive hazards models.Data-Adaptive Estimation for Double-Robust Methods in Population-Based Cancer Epidemiology: Risk differences for lung cancer mortality by emergency presentation.Changing patterns of use of osteoporosis medications in the years after launch: implications for comparative effectiveness research.
P2860
Q28487733-C038FCBD-0EE2-4892-AAA3-AAF977B02DFAQ30682561-3DB72539-2849-4E04-9580-F958B76518F0Q30875843-E5F25E05-6A3C-472D-8B90-B6873E121396Q34734413-844743D5-272B-4381-8B7F-A21983724CE3Q35056126-65104745-8856-46EF-A375-5C1BA773F89FQ35116507-0A2712BE-5C7C-4498-8F7B-8A697FE9DDEBQ36802843-3765273F-56CF-4277-8FC7-0C660A14AD3BQ37000713-44372463-4684-41DF-BCF6-26B2FF451494Q37164131-7AEE308A-C178-49E0-B13E-C3C9F1313A20Q37603566-63524977-199B-4962-8888-0A018EF183F3Q38754922-A5225DAB-5FFB-4C8F-97F6-3F98DFC7CAACQ45164813-E60FDC8F-909C-4D07-A8AC-CE52BA9BEBB6Q45344242-574B5A6A-D8F4-44D4-8E55-4A7E020E9CEAQ45945073-5CCFB39C-C74E-4519-9274-6EE3651E2597Q46262689-6BB7E828-C7A6-409E-AD35-044F63336884
P2860
Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Calendar time-specific propens ...... III colon cancer chemotherapy.
@en
type
label
Calendar time-specific propens ...... III colon cancer chemotherapy.
@en
prefLabel
Calendar time-specific propens ...... III colon cancer chemotherapy.
@en
P2093
P2860
P50
P356
P1476
Calendar time-specific propens ...... III colon cancer chemotherapy.
@en
P2093
Anne Marie Meyer
Christina DeFilippo Mack
Robert J Glynn
William R Carpenter
P2860
P304
P356
10.1002/PDS.3386
P577
2013-01-07T00:00:00Z